F
Clovis Oncology, Inc. CLVSQ
OTC PK
Recommendation
--
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
--
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2022 06/30/2022
Revenue -4.60% -6.14%
Total Other Revenue -- --
Total Revenue -4.60% -6.14%
Cost of Revenue -7.71% -2.45%
Gross Profit -3.60% -7.28%
SG&A Expenses -6.78% 11.56%
Depreciation & Amortization 0.00% 0.00%
Other Operating Expenses -61.46% 256.38%
Total Operating Expenses -18.17% 8.18%
Operating Income 25.51% -17.92%
Income Before Tax 21.57% -18.38%
Income Tax Expenses 185.37% 65.83%
Earnings from Continuing Operations 21.47% -18.55%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 21.47% -18.55%
EBIT 25.51% -17.92%
EBITDA 26.32% -18.67%
EPS Basic 21.79% -13.73%
Normalized Basic EPS 21.89% -13.61%
EPS Diluted 21.79% -13.73%
Normalized Diluted EPS 21.89% -13.61%
Average Basic Shares Outstanding 0.41% 4.22%
Average Diluted Shares Outstanding 0.41% 4.22%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings